Filter Results:
(660)
Show Results For
- All HBS Web
(660)
- People (2)
- News (224)
- Research (298)
- Events (4)
- Multimedia (12)
- Faculty Publications (181)
Show Results For
- All HBS Web
(660)
- People (2)
- News (224)
- Research (298)
- Events (4)
- Multimedia (12)
- Faculty Publications (181)
- 2018
- Working Paper
Two Hundred Years of Health and Medical Care: The Importance of Medical Care for Life Expectancy Gains
By: Maryaline Catillon, David Cutler and Thomas Getzen
Using two hundred years of national and Massachusetts data on medical care and health, we examine how central medical care is to life expectancy gains. While common theories about medical care cost growth stress growing demand, our analysis highlights the importance of... View Details
Keywords: Mortality; Life Expectancy; Medical Care; Productivity; Public Health; Healthcare Spending; Spending Per Year Of Life Gained; Personal Medicine; Technophysio Evolution; Health; Economics; Health Care and Treatment; Spending; Data and Data Sets; Health Industry
Catillon, Maryaline, David Cutler, and Thomas Getzen. "Two Hundred Years of Health and Medical Care: The Importance of Medical Care for Life Expectancy Gains." NBER Working Paper Series, No. 25330, December 2018.
- August 2023
- Teaching Note
Vanderbilt: Transforming an Academic Health Care Delivery System, 2020
By: Michael E. Porter, Robert S. Kaplan, Mary L. Witkowski and David N. Bernstein
Teaching Note for HBS Case No. 724-373. View Details
- August 2023
- Case
Vanderbilt: Transforming an Academic Health Care Delivery System, 2020
By: Michael E. Porter, Robert S. Kaplan, Mary L. Witkowski and David N. Bernstein
Keywords: Health Care; Health Care Industry; Academic Medicine; Value-based Health Care; Value-based Healthcare; Health Care Delivery; Service Delivery; Transformation; Health Care and Treatment; Corporate Strategy; Leadership; Health Industry; Tennessee; United States
Porter, Michael E., Robert S. Kaplan, Mary L. Witkowski, and David N. Bernstein. "Vanderbilt: Transforming an Academic Health Care Delivery System, 2020." Harvard Business School Case 724-373, August 2023.
- June 2014 (Revised February 2017)
- Case
Kathy Giusti and the Multiple Myeloma Research Foundation
By: Richard G. Hamermesh, Joshua D. Margolis and Matthew G. Preble
What do you do when your rising professional career is cut short by an unexpected cancer diagnosis? Kathy Giusti shifted careers, built a new organization that transformed how cancer research is done, and now faces the challenge of sustaining the organization and its... View Details
Keywords: Philanthropy; Philanthropy Funding; Entrepreneurship; Health Care; Management Styles; Personalized Medicine; Health Care Outcomes; Cancer; Cancer Care In The U.S.; Personal Care; Leadership; Leading Change; Social Entrepreneurship; Philanthropy and Charitable Giving; Health Care and Treatment; Leadership Style; Management Style; Management Skills; Growth and Development Strategy; Business Strategy; Health; Health Industry; United States; Canada; Spain
Hamermesh, Richard G., Joshua D. Margolis, and Matthew G. Preble. "Kathy Giusti and the Multiple Myeloma Research Foundation." Harvard Business School Case 814-026, June 2014. (Revised February 2017.)
- 29 Jan 2018
- News
B-School Bulletin: Fighting Cancer More Efficiently
- December 2014 (Revised October 2017)
- Case
Social Business at Novartis: Arogya Parivar
By: Michael E. Porter, Mark R. Kramer and David Lane
Late in 2013, Novartis CEO Joseph Jimenez was considering whether or how to deepen the company's investment in Arogya Parivar, its profitable program that sold Novartis medicines in rural India while expanding access to medicine and health information to millions of... View Details
Keywords: Shared Value; India; Kenya; Vietnam; Novartis; Arogya Parivar; Social Business; Multinational Firms and Management; Competitive Advantage; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Viet Nam; Kenya; India
Porter, Michael E., Mark R. Kramer, and David Lane. "Social Business at Novartis: Arogya Parivar." Harvard Business School Case 715-411, December 2014. (Revised October 2017.)
- 15 Jan 2018
- News
A Better Business Model for Fighting Cancer
- 09 Jul 2019
- Blog Post
Solving the Complexities of the Biotechnology Industry
Azita Sharif (MBA 2000) is the Founder and Chief Executive Officer of DSI- Precision Medicine Biobanking & BINDS (Bio-Informatics Network for Discovery Science). Her goal is to positively impact human and public health using... View Details
- 09 Jan 2019
- News
Perspectives on gene editing
- 21 Jun 2018
- Video
KPMA HBX Live Cracking the Data Aggregation Problem - Richard Hamermesh
- Apr 12 2017
- Testimonial
Driving Daily Change
- 8 Jun 2010
- Other Presentation
Value-Based Health Care Delivery
This presentation draws on Michael E. Porter and Elizabeth Olmsted Teisberg: Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press, May 2006, and Porter, Michael E. "A Strategy for Health Care Reform," New England... View Details
Porter, Michael E. "Value-Based Health Care Delivery." World Innovation Forum, New York City, NY, June 8, 2010.
- 4 Jun 2010
- Other Presentation
Value-Based Health Care Delivery
This presentation draws on Michael E. Porter and Elizabeth Olmsted Teisberg: Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press, May 2006, and Porter, Michael E. "A Strategy for Health Care Reform," New England... View Details
Porter, Michael E. "Value-Based Health Care Delivery." DHCS Health Care Seminar, University of California, Los Angeles and California Department of Health Care Services, Los Angeles, CA, June 4, 2010.
- 21 Jan 2016
- Video
2016 Precision Trials Challenge
- Video
Anand Burman
Anand Burman, Chairman of Dabur, one of India’s largest manufacturers of natural medicine and consumer products, discusses the Ayurvedic tradition behind his company’s products. View Details
- 01 Nov 2019
- Video
Devi Shetty
Devi Shetty, founder of India-based Narayana Heath, discusses his motivations for becoming a heart surgeon, as well as the challenges of practicing medicine in a developing country. View Details
- 09 Oct 2020
- Blog Post
4 Things To Know About the MS/MBA Biotech
Since emigrating from Syria at the age of five, I have personally experienced the uphill battle of obtaining health care coverage as a non-US citizen. My family, along with many other immigrant and low-income families, are often forced to choose between receiving care... View Details
- 31 Oct 2019
- Video
Anand Burman
Anand Burman, Chairman of Dabur, one of India’s largest manufacturers of natural medicine and consumer products, discusses the role of the Indian diaspora in the international growth of his... View Details
- March 2024
- Article
Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act
By: Matthew Vogel, Pragya Kakani, Amitabh Chandra and Rena M. Conti
The Inflation Reduction Act (IRA) requires Medicare to negotiate lower prices for some medicines with high Medicare spending. Using historical data from public and proprietary sources to apply the IRA's negotiation criteria retrospectively, we identify all drugs that... View Details
Keywords: Policy; Government Legislation; Health Care and Treatment; Negotiation; Price; Pharmaceutical Industry
Vogel, Matthew, Pragya Kakani, Amitabh Chandra, and Rena M. Conti. "Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act." Nature Biotechnology 42, no. 3 (March 2024): 406–412.
- 06 Jun 2018
- Video